The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs standard of care in patients with relapsed/refractory multiple myeloma (RRMM).
 
Joshua Richter
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genentech; Janssen; Karyopharm Therapeutics; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Adaptive Biotechnologies; Bristol-Myers Squibb; Janssen; Sanofi
 
Pragya Shukla
Employment - Evidera
Research Funding - GlaxoSmithKline (Inst)
 
Venediktos Kapetanakis
Employment - Evidera
Research Funding - GlaxoSmithKline (Inst)
 
Molly Purser
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sandhya Sapra
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Natalie Boytsov
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Nick Ballew
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline